MDT stock forecast: what analysts expect
Wall Street analysts covering Medtronic plc. currently rate the stock a Buy on average, with a mean 12-month price target of $98.44 — +8.5% versus the last price of $90.76. Targets reflect analyst opinion, not a guarantee.
MDT historical returns
Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in MDT.
MDT annual returns by year
Congress trading in MDT
35 members of Congress have disclosed trading MDT — 39 purchases and 27 sales worth an estimated $1.4M. Most recent disclosure: Nov 5, 2025.
See who in Congress traded MDT →Insider activity in MDT
MDT's own executives and directors have made 0 open-market purchases ($0) and 3 sales ($594,897) in the last 90 days, per SEC Form 4 filings. Most recent: Jul 8, 2026.
| Jul 8, 2026 | Walter Matthew R. | SVP, Chief HR Officer | Sell | $257,931 |
| Jun 8, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Sell | $318,623 |
| Jun 8, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Sell | $18,343 |
About Medtronic plc.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
MDT Key Statistics
MDT in plain English
- P/E ratio (24.3) — how many dollars you pay for each $1 of MDT's yearly profit. That's a fairly normal range.
- ROE (9.84%) — how efficiently the company turns shareholders' money into profit. This is a middling level.
- Profit margin (13.20%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend yield (3.18%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.
MDT stock: frequently asked questions
What is Medtronic plc.'s stock price today?
Medtronic plc. (MDT) last traded at $90.76 on the NYSE. Over the past 52 weeks the stock has traded between $73.31 and $106.33.
Is MDT stock a buy or a sell?
Wall Street analysts' consensus rating on MDT is "Buy", with an average 12-month price target of $98.44 — about +8.5% versus the current price of $90.76. Analyst targets are opinions, not guarantees; always do your own research.
How much would $1,000 invested in MDT 10 years ago be worth today?
A $1,000 investment in Medtronic plc. made 10 years ago would be worth about $1,354 today (dividends reinvested) — a total return of 35%, or 3.1% per year.
Does MDT pay a dividend?
Yes. Medtronic plc. currently pays a dividend yielding about 3.18% per year at today's share price.
What is MDT's P/E ratio?
MDT trades at a trailing price-to-earnings ratio of 24.3, and 14.2 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.
Do members of Congress trade MDT stock?
Yes — 35 members of Congress have disclosed trades in MDT under the STOCK Act, totaling 39 purchases and 27 sales worth an estimated $1.4M.
What is Medtronic plc.'s ticker symbol?
Medtronic plc. trades under the ticker symbol MDT on the NYSE.
Compare MDT with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.